RQ BIO
RQ Bio develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections. The company was co-founded by Paul Kellam, Mike Westby, and Jane Osbourn. The company is headquartered in London, United Kingdom.
RQ BIO
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2022-05-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.rqbiotechnology.com
Total Employee:
1+
Status:
Active
Current Employees Featured
Founder
Official Site Inspections
http://www.rqbiotechnology.com
- Host name: 198.185.159.144
- IP address: 198.185.159.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "RQ Bio"
RQ Bio
RQ Biotechnology Limited Scale Space 58 Wood Lane London, W12 7RZ United KingdomSee details»
RQ Bio — RQ Bio
RQ Biotechnology’s mission is to develop medicines based on potent broad-spectrum monoclonal antibodies to provide instant and long-lasting protection for vulnerable people. We are making instant immunity a reality for vulnerable …See details»
Our Science - RQ Bio
By discovering these potent antibodies, manufacturing them, and delivering them as a small injection, RQ Bio can produce instant, highly potent protection from infection and thereby limit …See details»
RQ Biotechnology Ltd. | LinkedIn
RQ Biotechnology is making instant immunity a reality for vulnerable people. As the leading passive immunization discovery company, we partner with pharmaceutical companies to …See details»
RQ Bio - Crunchbase Company Profile & Funding
RQ Bio develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections. The company was co-founded by Paul Kellam, Mike Westby, and Jane Osbourn. …See details»
AbCellera and RQ Bio Partner to Accelerate the …
Mar 22, 2023 · RQ Bio’s mission is to develop medicines based on potent broad-spectrum monoclonal antibodies (mAbs) to provide instant and long-lasting immunity for vulnerable people at risk of severe disease or death from current …See details»
Coulter Partners places two industry-leading infectious disease …
Feb 14, 2023 · RQ Bio’s mission has been to develop medicines based on potent broad-spectrum monoclonal antibodies to provide instant and long-lasting immunity for vulnerable people at …See details»
RQ Bio Launches with Goal to Transform Treatment and …
LONDON, May 17, 2022 /PRNewswire/ -- RQ Bio today emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of a successful …See details»
RQ Bio - VentureRadar
Website: https://www.rqbiotechnology.com/ Develops potent broad-spectrum mAbs medicines for instant, long-lasting immunity against viral infections, collaborating closely with the University …See details»
RQ Bio Launches with Goal to Transform Treatment and
LONDON, May 17, 2022 /PRNewswire/ -- RQ Bio today emerges from stealth mode announcing its launch as a new UK-based biotechnology company following the completion of a successful …See details»
LifeArc Co-founded RQ Bio Signs $157M AstraZeneca Deal - LifeArc
LONDON, UK, 17 May 2022 — LifeArc today announced that RQ Biotechnology Ltd (RQ Bio), a company it co-founded, has signed a licensing agreement with AstraZeneca PLC (AZN).See details»
RQ Biotechnology Ltd. - Company Profile & Staff Directory
RQ Bio is dedicated to developing treatments and preventative therapies based on potent broad-spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of …See details»
RQ Bio Strengthens Board with Industry-leading Infectious Disease ...
Feb 9, 2023 · RQ Bio's mission has been to develop medicines based on potent broad-spectrum monoclonal antibodies to provide instant and long-lasting immunity for vulnerable people at …See details»
RQ Biotechnology Ltd. - EU-Startups
RQ Bio plans to transform treatment and prevention of viral infectious diseases via antibody technologies. The medicines are based on potent broad-spectrum mAbs meant to provide …See details»
RQ Bio announces formation of Executive Committee with three …
Oct 3, 2022 · RQ Biotechnology Limited today formalises and strengthens its Executive Committee with three new appointments:See details»
Contact — RQ Bio - rqbiotechnology.com
RQ Biotechnology Limited Scale Space 58 Wood Lane London, W12 7RZ United KingdomSee details»
AbCellera and RQ Bio Partner to Accelerate the Advancement of …
Mar 22, 2023 · RQ Bio’s mission is to develop medicines based on potent broad-spectrum monoclonal antibodies (mAbs) to provide instant and long-lasting immunity for vulnerable …See details»
Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of ...
LONDON, Dec. 21, 2022 /PRNewswire/ -- RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients, AZD3152, has entered …See details»
RQ Bio Strengthens Board with Industry-leading Infectious Disease ...
Feb 9, 2023 · RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr W. Ripley (“Rip”) Ballou and Dr Jacques Cholat to its Board of Directors.See details»
RQ Bio Launch press release — RQ Bio - rqbiotechnology.com
May 16, 2022 · RQ Bio Launches with goal to transform treatment and prevention of viral infectious diseases through antibody technologiesSee details»